# US 2024/0002824 A1 · Protein compositions and methods of production

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002824 A1
- Document ID: US20240002824A1
- Status: Published application
- Kind: A1
- Application number: 18/344,773
- Filed: 2023-06-29
- Published: 2024-01-04
- Earliest claimed: 2022-06-29
- Applicants: Clara Foods Co.
- Inventors: Logan HURST; Weixi ZHONG; Charles Albert TINDELL; Lauren KOLYER; Ranjan PATNAIK
- Web page: https://patentgrep.com/patent/US20240002824A1

## CPC

- C12N 9/2431: {Beta-fructofuranosidase (3.2.1.26), i.e. invertase}
- C12N 1/165: Yeast isolates
- C12N 9/2402: {hydrolysing O- and S- glycosyl compounds (3.2.1)}
- C12Y 302/01026: Beta-fructofuranosidase (3.2.1.26), i.e. invertase
- C07K 2319/035: containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Provided are systems and methods for recombinant proteins in microorganisms engineered to use alternate carbon sources.

## Claims

### Claim 1

An engineered host cell comprising:
an integrated coding sequence of a fusion protein comprising a catalytic domain of a heterologous glycosyl hydrolase; and
an integrated coding sequence of a heterologous protein of interest (POI);
wherein the engineered host cell does not endogenously express the glycosyl hydrolase and the POI; and
wherein the glycosyl hydrolase is anchored on the surface of the engineered host cell.

### Claim 2 (depends on 1)

The engineered host cell of claim 1, wherein the glycosyl hydrolase is an invertase selected from: S. cerevisiae, Kluyveromyces lactis, Cyberlindnera jadinii, Oryza sativa japonica (rice), Oryza sativa japonica (rice), Arabidopsis thaliana, Arabidopsis thaliana, Arabidopsis thaliana, Rattus norvegicus (rat), Oryctolagus cuniculus (Rabbit), and Homo sapiens.

### Claim at position 3

3-4. (canceled)

### Claim 5 (depends on 1)

The engineered host cell of claim 1, wherein the invertase is encoded by a gene selected from: SUC2, MAL1, invertase (INV1), cytosolic invertase 1 (CINV1), CIN2, CINV1, INVA, INVE, and sucrase-isomaltase (SI) gene.

### Claim 6 (depends on 1)

The engineered host cell of claim 1, wherein the fusion protein is surface-displayed on the engineered host cell; wherein the surface-displayed fusion protein comprises a catalytic domain of the glycosyl hydrolase and an anchoring domain of a glycosylphosphatidylinositol (GPI)-anchored protein, wherein the anchoring domain comprises at least about 200 amino acids and/or at least about 30% of the residues in the anchoring domain are serines or threonines.

### Claim at position 6

7-8. (canceled)

### Claim 9 (depends on 8)

The engineered host cell of claim 8, wherein the serines or threonines in the anchoring domain are capable of being O-mannosylated.

### Claim 10 (depends on 6)

The engineered host cell of claim 6, wherein a fusion protein having an anchoring domain comprising at least about 325 amino acids provides greater glycosyl hydrolase activity relative to a fusion protein having an anchoring domain comprising less than about 300 amino acids or less than about 250 amino acids.

### Claim at position 9

11-12. (canceled)

### Claim 13 (depends on 1)

The engineered host cell of claim 1, wherein the fusion protein comprises the GPI anchored protein without its native signal peptide or native secretory signal to the engineering host cell.

### Claim 14

(canceled)

### Claim 15 (depends on 1)

The engineered host cell of claim 1, wherein the GPI anchored protein is naturally expressed by a S. cerevisiae cell and the engineered host cell is not a S. cerevisiae cell.

### Claim 16 (depends on 13)

The engineered host cell of claim 13, wherein the GPI anchored protein is selected from Tir4, Dan1, or Sed1.

### Claim 17 (depends on 1)

The engineered host cell of claim 1, wherein an anchoring domain of the GPI anchored protein comprises an amino acid sequence that is at least 70% identical to one of SEQ ID NO: 1 to SEQ ID NO: 14.

### Claim 18

(canceled)

### Claim 19 (depends on 1)

The engineered host cell of claim 1, wherein the engineered host cell is a yeast cell or a Pichia species.

### Claim 20

(canceled)

### Claim 21 (depends on 19)

The engineered host cell of claim 19, wherein the Pichia species is Pichia pastoris.

### Claim 22 (depends on 1)

The engineered host cell of claim 1, wherein the engineered host cell comprises a genomic modification that expresses the fusion or a portion of the glycosyl hydrolase in addition to its catalytic domain.

### Claim at position 20

23-24. (canceled)

### Claim 25 (depends on 1)

The engineered host cell of claim 1, wherein in the fusion protein, the catalytic domain is N-terminal to the anchoring domain, or wherein in the fusion protein, the catalytic domain is C-terminal to the anchoring domain.

### Claim 26

(canceled)

### Claim 27 (depends on 1)

The engineered host cell of claim 1, wherein the fusion protein comprises a linker between the catalytic domain and the anchoring domain.

### Claim 28

(canceled)

### Claim 29 (depends on 1)

The engineered host cell of claim 1, wherein a growth rate of the engineered host cell in a media containing sucrose as a primary carbon source is higher than a growth rate of a control host cell, wherein the control host cell is identical to the engineered host cell, except the control cell does not express the glycosyl hydrolase.

### Claim 30 (depends on 1)

The engineered eukaryotic cell of claim 1, wherein the engineered eukaryotic cell comprises a genomic modification that overexpresses a secreted recombinant protein and/or comprises an extrachromosomal modification that overexpresses a secreted recombinant protein.

### Claim 31 (depends on 30)

The engineered eukaryotic cell of claim 30, wherein the secreted recombinant protein is an egg protein.

### Claim 32

(canceled)

### Claim 33 (depends on 31)

The engineered eukaryotic cell of claim 31, wherein the egg protein is selected from the group consisting of ovalbumin, ovomucoid, lysozyme ovoglobulin G2, ovoglobulin G3, α-ovomucin, β-ovomucin, ovotransferrin, ovoinhibitor, ovoglycoprotein, flavoprotein, ovomacroglobulin, ovostatin, cystatin, avidin, ovalbumin related protein X, and ovalbumin related protein Y.

### Claim 34 (depends on 30)

The engineered eukaryotic cell of claim 30, wherein the genomic modification and/or the extrachromosomal modification that overexpresses the secreted recombinant protein comprises an inducible promoter selected from an A0X1, DAK2, PEX11, FLD1, FGH1, DAS1, DAS2, CAT1, MDH3, HAC1, BiP, RAD30, RVS161-2, MPP10, THP3, TLR, GBP2, PMP20, SHB17, PEX8, PEX4, or TKL3 promoter, and/or a terminator selected from an AOX1, TDH3, MOX, RPS25A, or RPL2A terminator.

### Claim at position 31

35-36. (canceled)

### Claim 37 (depends on 30)

The engineered eukaryotic cell of claim 30, wherein the genomic modification and/or the extrachromosomal modification that overexpresses a secreted recombinant protein encodes a signal peptide, a secretory signal, and/or codons that are optimized for the species of the engineered eukaryotic cell.

### Claim 38

(canceled)

### Claim 39 (depends on 30)

The engineered eukaryotic cell of claim 30, wherein the secreted recombinant protein is designed to be secreted from the cell and/or is capable of being secreted from the cell.

### Claim 40 (depends on 1)

The engineered eukaryotic cell of claim 1, wherein the fusion protein comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the amino acid sequence selected from SEQ ID NOs: 315, 332-335, and 342.

### Claim 41 (depends on 1)

The engineered eukaryotic cell of claim 1, wherein the fusion protein comprises a nucleotide sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical to the nucleotide sequence of SEQ ID ON: 314.

### Claim 42 (depends on 1)

A method of growing/culturing the engineered host cell of claim 1, wherein the method comprises culturing the engineered host cell with a carbon source that is not naturally utilized by the host cell in the absence of the glycosyl hydrolase.

### Claim 43

A method for growing/culturing a host cell with a carbon source that is not naturally utilized by the host cell, the method comprising:
(a) recombinantly producing in the host cell, a fusion protein comprising a catalytic domain of a glycosyl hydrolase capable of digesting sucrose; optionally, wherein the glycosyl hydrolase capable of digesting sucrose is an invertase;
(b) recombinantly producing in the host cell a heterologous protein of interest (POI);
wherein the host cell does not express the glycosyl hydrolase endogenously;
wherein the engineered host cell prior to step (a) does not utilize sucrose as a carbon source as efficiently as glucose, and wherein the glycosyl hydrolase is expressed on the surface of the engineered host cell.

### Claim 44

A method for manufacturing a host cell capable of utilizing a carbon source that is not naturally utilized by the host cell, the method comprising:
(a) obtaining a host cell that recombinantly expresses a fusion protein comprising a catalytic domain of a glycosyl hydrolase capable of digesting sucrose,
wherein the glycosyl hydrolase capable of digesting sucrose is an invertase; and
(b) genetically modifying the host cell to express a heterologous protein of interest (POI);
wherein the host cell does not utilize sucrose as a carbon source as efficiently as glucose in the absence of the glycosyl hydrolase.

### Claim 45

A method for manufacturing a host cell capable of utilizing a carbon source that is not naturally utilized by the host cell, the method comprising:
(a) obtaining a host cell that recombinantly expresses a heterologous protein of interest (POI); and
(b) genetically modifying the host cell to express a fusion protein comprising a catalytic domain of a glycosyl hydrolase capable of digesting sucrose;
wherein the glycosyl hydrolase capable of digesting sucrose is an invertase;
wherein the host cell prior to step (b) does not utilize sucrose as a carbon source as efficiently as glucose.
